Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Sajan Khosla
AstraZeneca Pharmaceuticals - UK
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
38
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Pan-Cancer Analysis in the Real-World Setting Uncovers Immunogenomic Drivers of Acquired Resistance Post-Immunotherapy
Number of pages: 52
Posted: 30 Jul 2025
Mohamed Reda Keddar
,
Sebastian Carrasco Pro
,
Roy Rabbie
,
Zeynep Kalender Atak
,
Ana Camelo Stewart
,
Scott A. Hammond
,
Douglas C. Palmer
,
Ross Stewart
,
Kathleen Burke
,
Ben Sidders
,
Jessica Davies
,
Jonathan Dry
,
Inigo Martincorena
, Sajan Khosla,
Adam J. Schoenfeld
,
Martin L. Miller
and
Sneak Peek Administrator
AstraZeneca Pharmaceuticals - UK, Boehringer Ingelheim Pharmaceuticals Inc, AstraZeneca Pharmaceuticals - UK, Quotient Therapeutics Inc, AstraZeneca Pharmaceuticals - UK, AstraZeneca Pharmaceuticals - AstraZeneca R&D, AstraZeneca Pharmaceuticals - AstraZeneca R&D, AstraZeneca Pharmaceuticals - UK, Tempus AI, Inc., Biorelate Ltd, AstraZeneca Farmaceutica Spain SA, Tempus AI, Inc., Wellcome Sanger Institute, AstraZeneca Pharmaceuticals - UK, Memorial Sloan Kettering Cancer Center, AstraZeneca Pharmaceuticals - UK and Independent
Downloads
38
(1,236,159)
View PDF
Download
Abstract:
cancer immunotherapy, acquired resistance, immunogenomics, real-world data
Feedback
